Cellular DNA at Octamer-binding transcription factor 4 (Oct4), SRY-box transcription factor 2 (Sox2), and Kruppel-like factor 4 (Klf4) binding sites (OSK binding sites)

Cellular DNA at OSK transcription-factor binding sites refers to the specific genomic sequences recognized and bound by the transcription factors Octamer-binding transcription factor 4 (Oct4), SRY-box transcription factor 2 (Sox2), and Kruppel-like factor 4 (Klf4). These sites are central to the regulation of pluripotency and cellular identity, acting as hubs for the recruitment of chromatin-remodeling complexes and transcriptional machinery [1][3]. In therapeutic contexts, these DNA sites are the primary targets for epigenetic rejuvenation therapies, where the exogenous expression of OSK factors is used to reset the epigenetic landscape of aged cells [1][2]. By altering the methylation patterns and chromatin accessibility at these specific loci, the therapy aims to restore a more youthful gene expression profile without inducing full dedifferentiation into a pluripotent state [2][4]. This mechanism has demonstrated potential in reversing age-related vision loss and promoting nerve regeneration in preclinical models [1]. However, targeting these sites carries significant risks, including the potential for uncontrolled cell growth or the loss of essential somatic cell functions if the reprogramming process is not strictly controlled [2][3]. Citations: [1] Lu, Y., et al. (2020). Nature 588, 124–129. [2] Ocampo, A., et al. (2016). Cell 167, 1719–1733. [3] Takahashi, K., & Yamanaka, S. (2006). Cell 126, 663–676. [4] Life Biosciences. (2023). Epigenetic Reprogramming Platform.

Other names

OSK motifsOSK-responsive elementsPluripotency factor binding sitesYamanaka factor binding sites (subset)OSK-binding genomic loci

Epigenetic remodeling and DNA demethylation at specific genomic loci to restore youthful gene expression patterns and promote tissue regeneration.